We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

92 hedge funds and large institutions have $230M invested in Minerva Neurosciences in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

431% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $194K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

6% more funds holding

Funds holding: 87 → 92 (+5)

0.51% more ownership

Funds ownership: 9.86% → 10.37% (+0.51%)

4% less capital invested

Capital invested by funds: $239M → $230M (-$8.41M)

Holders
92
Holders Change
+5
Holders Change %
+5.75%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
25
Increased
30
Reduced
22
Closed
20
Calls
$1.03M
Puts
$194K
Net Calls
+$837K
Net Calls Change
+$951K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$3.09M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.85M
3
JGC
J. Goldman & Co
New York
+$1.38M
4
Millennium Management
Millennium Management
New York
+$898K
5
Federated Hermes
Federated Hermes
Pennsylvania
+$795K

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$4.68M
2
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
-$1.98M
3
BlackRock
BlackRock
New York
-$1.62M
4
NAM
Nexpoint Asset Management
Texas
-$1.47M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
IHAM
26
Integral Health Asset Management
New York
$1.28M +$992K +22,500 New
Squarepoint
27
Squarepoint
New York
$1.27M +$723K +16,394 +275%
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$984K -$27.3K -619 -3%
N
29
Nuveen
North Carolina
$815K -$509K -11,534 -45%
Barclays
30
Barclays
United Kingdom
$730K +$482K +10,929 +571%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$715K -$127K -2,871 -19%
IC
32
Ikarian Capital
Texas
$711K +$551K +12,500 New
Arrowstreet Capital
33
Arrowstreet Capital
Massachusetts
$674K +$523K +11,857 New
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$618K +$268K +6,081 +127%
AllianceBernstein
35
AllianceBernstein
Tennessee
$598K – – –
Goldman Sachs
36
Goldman Sachs
New York
$597K -$11.2K -253 -2%
MCM
37
Moore Capital Management
New York
$533K -$111K -2,516 -21%
BCM
38
Bridgeway Capital Management
Texas
$531K – – –
Charles Schwab
39
Charles Schwab
California
$519K +$17.6K +398 +5%
HF
40
HRT Financial
New York
$517K +$401K +9,099 New
AWCI
41
Alpine Woods Capital Investors
New York
$429K – – –
Verition Fund Management
42
Verition Fund Management
Connecticut
$410K -$277K -6,285 -47%
GCP
43
GSA Capital Partners
United Kingdom
$391K +$303K +6,867 New
TD Asset Management
44
TD Asset Management
Ontario, Canada
$349K -$6.62K -150 -2%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$344K +$16K +363 +6%
Morgan Stanley
46
Morgan Stanley
New York
$307K +$152K +3,436 +175%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$301K – – –
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$296K +$5.73K +130 +3%
Group One Trading
49
Group One Trading
Illinois
$272K +$211K +4,788 New
UBS Group
50
UBS Group
Switzerland
$265K +$111K +2,526 +119%
1
2
3 4 5

NERV Hedge Fund Activity: Q4 2019 in Review

92 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2019, worth a combined $230M — down 3.5% from $239M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new NERV positions and 20 closed out — a net gain of 5 holders — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $3.09M. The largest seller was GMT Capital, exiting entirely with an estimated $4.68M sold.

  • 92 institutional investors held Minerva Neurosciences (NERV) as of Q4 2019, up from 87 in Q3 2019.
  • Funds reported $230M of Minerva Neurosciences stock for Q4 2019, down 3.5% quarter-over-quarter.
  • 25 funds opened new Minerva Neurosciences positions in Q4 2019 and 20 closed out, a net change of +5 holders.
  • The largest Minerva Neurosciences buyer in Q4 2019 was Armistice Capital, an estimated $3.09M added.
  • The largest Minerva Neurosciences seller in Q4 2019 was GMT Capital, an estimated $4.68M sold.

Based on aggregated 13F filings for Q4 2019.